Soligenix Closes IPO at $7.1 Mln

Soligenix has closed its IPO at $7.1 million at 6,773,995 shares. Investors include Third Security as well as members of Soligenix's management and board. Maxim Group LLC was the lead placement agent for the offering while Griffin Securities served as a sub-agent. Headquartered in Princeton, NJ, Soligenix is a clinical stage biopharmaceutical company.

DealsNorth AmericaUSBriefs